Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 20;12(6):697.
doi: 10.3390/vaccines12060697.

Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries

Thomas D Filardo  1 , Stephen N Crooke  1 , Bettina Bankamp  1 , Kelley Raines  1 , Adria D Mathis  1 , Tatiana M Lanzieri  1 , R Suzanne Beard  1 , Ludmila Perelygina  1 , David E Sugerman  1 , Paul A Rota  1
Affiliations
Review

Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries

Thomas D Filardo et al. Vaccines (Basel). .

Abstract

Measles and rubella are vaccine-preventable viral diseases and can be prevented by safe, highly effective vaccination with measles- and rubella-containing vaccines. Given the myriad causes of febrile exanthems, laboratory surveillance for both measles and rubella is important to document the incidence of these diseases and to track the progress and maintenance of elimination in near- and post-elimination settings. Diagnostic challenges can hinder effective surveillance and classification challenges can hinder efforts to demonstrate achievement or maintenance of elimination. In this report, we review diagnostic and classification challenges for measles and rubella in near- and post-elimination settings.

Keywords: elimination; measles; rubella; viral diagnostics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. WHO Global Vaccine Action Plan 2011–2020. [(accessed on 7 September 2023)]. Available online: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategi....
    1. Minta A.A., Ferrari M., Antoni S., Portnoy A., Sbarra A., Lambert B., Hatcher C., Hsu C.H., Ho L.L., Steulet C., et al. Progress Toward Measles Elimination—Worldwide, 2000–2022. MMWR Morb. Mortal. Wkly. Rep. 2023;72:1262–1268. doi: 10.15585/mmwr.mm7246a3. - DOI - PMC - PubMed
    1. Ou A.C., Zimmerman L.A., Alexander J.P., Jr., Crowcroft N.S., O’Connor P.M., Knapp J.K. Progress Toward Rubella and Congenital Rubella Syndrome Elimination—Worldwide, 2012–2022. MMWR Morb. Mortal. Wkly. Rep. 2024;73:162–167. doi: 10.15585/mmwr.mm7308a2. - DOI - PMC - PubMed
    1. World Health Organization Immunization Agenda 2030: A Global Strategy to Leave No One Behind. [(accessed on 7 September 2023)]. Available online: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategi....
    1. Mulders M.N., Rota P.A., Icenogle J.P., Brown K.E., Takeda M., Rey G.J., Ben Mamou M.C., Dosseh A.R., Byabamazima C.R., Ahmed H.J., et al. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010–2015. MMWR Morb. Mortal. Wkly. Rep. 2016;65:438–442. doi: 10.15585/mmwr.mm6517a3. - DOI - PubMed